Literature DB >> 26854289

Neutrophils in cystic fibrosis.

Julie Laval, Anjali Ralhan, Dominik Hartl.   

Abstract

Cystic fibrosis (CF) lung disease is characterized by chronic infection and inflammation. Among inflammatory cells, neutrophils represent the major cell population accumulating in the airways of CF patients. While neutrophils provide the first defensive cellular shield against bacterial and fungal pathogens, in chronic disease conditions such as CF these short-lived immune cells release their toxic granule contents that cause tissue remodeling and irreversible structural damage to the host. A variety of human and murine studies have analyzed neutrophils and their products in the context of CF, yet their precise functional role and therapeutic potential remain controversial and incompletely understood. Here, we summarize the current evidence in this field to shed light on the complex and multi-faceted role of neutrophils in CF lung disease.

Entities:  

Mesh:

Year:  2016        PMID: 26854289     DOI: 10.1515/hsz-2015-0271

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  34 in total

1.  Paucimannose-Rich N-glycosylation of Spatiotemporally Regulated Human Neutrophil Elastase Modulates Its Immune Functions.

Authors:  Ian Loke; Ole Østergaard; Niels H H Heegaard; Nicolle H Packer; Morten Thaysen-Andersen
Journal:  Mol Cell Proteomics       Date:  2017-06-19       Impact factor: 5.911

Review 2.  Hyperinflammation and airway surface liquid dehydration in cystic fibrosis: purinergic system as therapeutic target.

Authors:  Thiago Inácio Teixeira do Carmo; Victor Emanuel Miranda Soares; Jonatha Wruck; Fernanda Dos Anjos; Débora Tavares de Resende E Silva; Sarah Franco Vieira de Oliveira Maciel; Margarete Dulce Bagatini
Journal:  Inflamm Res       Date:  2021-04-27       Impact factor: 4.575

Review 3.  Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine.

Authors:  Dominik Hartl; Rabindra Tirouvanziam; Julie Laval; Catherine M Greene; David Habiel; Lokesh Sharma; Ali Önder Yildirim; Charles S Dela Cruz; Cory M Hogaboam
Journal:  J Innate Immun       Date:  2018-02-13       Impact factor: 7.349

Review 4.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

5.  Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses.

Authors:  Frank H Robledo-Avila; Juan de Dios Ruiz-Rosado; Kenneth L Brockman; Benjamin T Kopp; Amal O Amer; Karen McCoy; Lauren O Bakaletz; Santiago Partida-Sanchez
Journal:  J Immunol       Date:  2018-08-17       Impact factor: 5.422

6.  Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.

Authors:  Timothy J Bensman; Jordanna G Jayne; Meiling Sun; Elza Kimura; Joshua Meinert; Joshua C Wang; Justin B Schaal; Dat Tran; Adupa P Rao; Omid Akbari; Michael E Selsted; Paul M Beringer
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

7.  Myeloid CFTR loss-of-function causes persistent neutrophilic inflammation in cystic fibrosis.

Authors:  Hang Pong Ng; Scott Jennings; Dianne Wellems; Fei Sun; Jie Xu; William M Nauseef; Guoshun Wang
Journal:  J Leukoc Biol       Date:  2020-06-12       Impact factor: 4.962

8.  Frontline Science: Pathological conditioning of human neutrophils recruited to the airway milieu in cystic fibrosis.

Authors:  Osric A Forrest; Sarah A Ingersoll; Marcela K Preininger; Julie Laval; Dominique H Limoli; Milton R Brown; Frances E Lee; Brahmchetna Bedi; Ruxana T Sadikot; Joanna B Goldberg; Vin Tangpricha; Amit Gaggar; Rabindra Tirouvanziam
Journal:  J Leukoc Biol       Date:  2018-05-09       Impact factor: 4.962

Review 9.  Neutrophils as emerging therapeutic targets.

Authors:  Tamás Németh; Markus Sperandio; Attila Mócsai
Journal:  Nat Rev Drug Discov       Date:  2020-01-22       Impact factor: 84.694

Review 10.  Proteases, Mucus, and Mucosal Immunity in Chronic Lung Disease.

Authors:  Michael C McKelvey; Ryan Brown; Sinéad Ryan; Marcus A Mall; Sinéad Weldon; Clifford C Taggart
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.